drugset / Trial / NCT00816712

A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064)

NCT00816712

Phase 1 Completed 28 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a study to evaluate the use of fractional synthetic rate as an early biomarker of muscle anabolism (muscle build-up).

Timeline

Start
2008-01
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 100 mg Intramuscular
Comparator Testosterone Small molecule 300 mg Intramuscular

Indications

No indication recorded.